Document is current
Any future updates will be listed below
-
Authors
Salmon, Matthew
White, Helen E.
Zizkova, Hana
Gottschalk, Andrea
Motlova, Eliska
Cerveira, Nuno
Colomer, Dolors https://orcid.org/0000-0001-7486-8484
Coriu, Daniel
Franke, Georg N. https://orcid.org/0000-0001-8239-002X
Gottardi, Enrico
Izzo, Barbara https://orcid.org/0000-0002-7021-0367
Jurcek, Tomas
Lion, Thomas
Schäfer, Vivien
Venturi, Claudia
Vigneri, Paolo
Zawada, Magdalena
Zuna, Jan https://orcid.org/0000-0002-0887-3709
Hovorkova, Lenka https://orcid.org/0000-0001-8980-8441
Koblihova, Jitka
Klamova, Hana
Markova, Marketa Stastna
Srbova, Dana
Benesova, Adela
Polivkova, Vaclava
Zackova, Daniela
Mayer, Jiri
Roeder, Ingo https://orcid.org/0000-0002-6741-0608
Glauche, Ingmar https://orcid.org/0000-0002-2524-1199
Ernst, Thomas https://orcid.org/0000-0003-2147-489X
Hochhaus, Andreas https://orcid.org/0000-0003-0626-0834
Polakova, Katerina Machova https://orcid.org/0000-0002-7398-5555
Cross, Nicholas C. P. https://orcid.org/0000-0001-5481-2555
-
Funding
Funding for this research was provided by:
EUTOS
- License Information
-
More Information
Article History
Received: 28 March 2022
Revised: 16 May 2022
Accepted: 20 May 2022
First Online: 8 June 2022
Competing interests
: HEW, MS, GNF, KMP, TE, NCPC and AH received support from Novartis through the European Treatment and Outcome Study (EUTOS) for CML. HW has received honoraria from Novartis. GNF has received honoraria from BMS, Novartis and Pfizer. TL has received honoraria from Incyte, Novartis, Pfizer, Angelini, Bristol Myers Squibb and research support from Incyte, Novartis and Pfizer. PV has received honoraria from Astra-Zeneca, Eli Lilly, Gilead; GlaxoSmithKline, Novartis, Pfizer, Roche, Teva and research support from Novartis and Pfizer. IR has received research support from Bristol-Myers Squibb and honoraria from Bristol Myers-Squibb and Janssen-Cilag. IG has received research support from Bristol-Myers Squibb. AH received research support from Novartis, BMS, Pfizer and Incyte. KMP has received honoraria from Angelini and Incyte. NCPC has received research support and honoraria from Novartis, and honoraria from Incyte and Astellas.
: This work involving patient samples and data was conducted in accordance with the principles of the Declaration of Helsinki and was approved by the Ethics Committees of the Institute of Haematology and Blood Transfusion, Prague and Faculty Hospital Brno. All patients provided written informed consent for the use of their samples for this research.
